Patent Yard Sign in
Canadian application, no grantCanada

Quinazolines for treating brain tumor

CA 2333392 A1 · Owner: Liu, Xing-Ping · Inventors: Uckun, Fatih M.; Narla, Rama K.; Liu, Xing-Ping

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel substituted quinazoline compounds and conjugates useful to inhibit the growth of brain tumor cells and to inhibit adhesion and migration of brain tumor cells. The compounds of the invention include 4-(3'-bromo-4'-hydroxy phenyl)-amino-6,7-dimethoxyquinazoline and this compound covalently bound to EGF.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 28, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 28, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 28, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 28, 1999
GrantedNo grant recorded
Term endedMay 28, 2019
Patent numberCA 2333392 A1
Classification (IPC)C07D239/94 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedMay 28, 1999Term endedMay 28, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.